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Abstract: Serological data areoneof theprimary sourcesof information fordiseasemonitoring inwildlife.However, the
duration of the seropositive status of exposed individuals is almost always unknown formany free-ranging host species.
Directly estimating rates of antibody loss typically requires difficult longitudinal sampling of individuals following
seroconversion. Instead, we propose a Bayesian statistical approach linking age and serological data to a mechanistic
epidemiological model to infer brucellosis infection, the probability of antibody loss, and recovery rates of elk (Cervus
canadensis) in the Greater Yellowstone Ecosystem.We found that seroprevalence declined above the age of ten, with no
evidence of disease-inducedmortality. The probability of antibody loss was estimated to be 0.70 per year after a five-year
periodof seropositivity and thebasic reproductionnumber forbrucellosis to 2.13.Our results suggest that individuals are
unlikely to become re-infected because models with this mechanism were unable to reproduce a significant decline in
seroprevalence in older individuals. This study highlights the possible implications of antibody loss, which could bias our
estimation of critical epidemiological parameters for wildlife disease management based on serological data.
Keywords: Antibody loss, Approximate Bayesian computation, Brucellosis, Greater Yellowstone Ecosystem,
Basic reproduction number, Serology
INTRODUCTION
Many disease monitoring programs in wildlife rely on
serology to infer disease prevalence (Gilbert et al. 2013). A
positive serological response indicates previous exposure to
a pathogen because specific antibody titers can remain at a
detectable concentration long after an initial infection
(Fredriksen et al. 1999). If antibodies are long-lived, then
serological data can be used to estimate the force of
infection as well as the vaccination coverage that may be
required for eradication (Farrington et al. 2001; Hens et al.
2010). However, the probability of antibody loss following
infection is generally unknown for most wildlife systems
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(Gilbert et al. 2013). This can potentially result in biased
estimates of epidemiological parameters such as the R0,
which is the expected number of infections caused by a
typical infectious individual in a completely susceptible
population (Anderson et al. 1992). In humans, antibodies
to common viral and vaccine antigens persist for extended
periods of time (Amanna et al. 2007). By contrast, anti-
bodies to other pathogens, particularly bacteria, decline
several months or years after the first infection [e.g, per-
tussis (Edwards 2005), cholera (Clements et al. 1982),
chlamydia (Gijsen et al. 2002)].
Estimating the probability of antibody loss, referred here
as the annual probability of a previously infected seropositive
individual becoming seronegative, typically requires fol-
lowing individuals for several years post-infection (Clements
et al. 1982; Fredriksen et al. 1999). This also requires ensuring
that the individual does not get re-exposed. Given logistical
constraints, this is typically not feasible for most wildlife
systems. Alternatively, the probability of antibody loss can be
estimated using novel statistical methods consisting in fitting
mechanistic simulation models to observed patterns (Toni
et al. 2009). In this study, we use a similar Bayesian modeling
approach to Toni et al. (2009) to fit different disease sce-
narios to age-specific seroprevalence data in order to esti-
mate the annual probability of antibody loss.
The purpose of this study is to estimate the probability
of antibody loss and to investigate the duration of post-
infection immunity to brucellosis in elk (Cervus canadensis)
using empirical age–seroprevalence data. Brucellosis, a
bacterial disease, is the most common zoonotic infection
worldwide (Pappas et al. 2006) and prevention in humans
requires a good understanding of its circulation in animal
reservoirs (Seleem et al. 2010). In the USA, brucellosis
caused by Brucella abortus remains in the free-ranging elk
and bison (Bison bison) populations around the Greater
Yellowstone Ecosystem (GYE). Brucellosis continues to
threaten the livestock economy in the area when trans-
mission from wildlife to cattle occurs (Cross et al. 2010).
Disease transmission likely occurs from February to June,
when susceptible individuals become infected through
contact with an infected aborted fetus, placenta or fluids
(Cheville et al. 1998). Campaigns to limit brucellosis in elk
include vaccination with strain 19 on Wyoming’s 21 feed-
grounds and the National Elk Refuge since 1985 (Herriges
et al. 1992; Scurlock and Edwards 2010), whereby over 90%
of juvenile elk (less than 2 years old) are vaccinated with a
biobullet. However, current vaccines induce poor protec-
tion from brucellosis in elk compared to bison or cattle,
because they do not induce robust and persistent
immunological response in this species (Herriges et al.
1992; Olsen et al. 2006).
Previous studies have suggested that older bison could
experience antibody loss (Joly and Messier 2004; Treanor
et al. 2011). In addition, decreasing antibody titers have been
observed for vaccination strains in elk (Olsen et al. 2006).
However, no studies have attempted to quantify antibody
loss in free-ranging elk. Furthermore, antibody loss could
result in at least two very distinct epidemiological scenarios.
Antibody loss can be accompanied by a loss of adaptive hu-
moral immunity to a particular pathogen after it has been
removed by the immune response, allowing the individual to
become infected again when re-exposed to the same patho-
gen (Edwards 2005). Alternatively, antibody loss can be fol-
lowed by an adaptive cell-mediated immune response
conferring long-term immunity without involving antibod-
ies (Takaki et al. 2000), which is a mechanism suggested for
intracellular bacteria such as Brucella spp. (Yingst and Ho-
over 2003). Here, we intend to discriminate between the
above two epidemiological scenarios confronting three dif-
ferent models of brucellosis dynamics: (1) a brucellosis epi-
demiological model without antibody loss, (2) a model with
antibody loss and further re-exposure and (3) a model with
antibody loss and lifelong immunity. Our models assumed
no vertical transmission from an infected mother to its off-
spring [as previously described for elk brucellosis (Thorne
et al. 1978)] nor disease recrudescence (shown in humans
(Pellicer et al. 1988) but not described for elk). Given the
vaccination campaigns to control brucellosis in elk on
Wyoming feedgrounds (Maichak et al. 2017), we also focused
on estimating how antibody loss can affect the calculation of
the basic reproduction number R0. From R0, we estimated
the associated vaccination coverage needed to eradicate the
disease, if a more effective vaccine were to become available.
METHODS AND MODELS
Empirical Data
Three datasets were used in this study for different pur-
poses: (1) The first dataset was used to reconstruct the age–
seroprevalence curve, estimate the effect of age on sero-
prevalence and estimate antibody loss using the approxi-
mate Bayesian computation-sequential Monte Carlo (ABC-
SMC) model fit to age–seroprevalence data, (2) the second
dataset included individuals tested over multiple years to
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estimate antibody loss independently of the ABC-SMC, and
(3) the third dataset was used to estimate brucellosis dis-
ease-induced mortality from collared animals. The first
dataset included 478 serologic assays for exposure to bru-
cellosis of elk females captured from the Grey’s River
feedground near Alpine, Wyoming, USA. Details on blood
sample collection, serological methods and the empirical
data used in this study are provided in Sect. 1 of Supple-
mentary Material. Grey’s River elk population sizes were
extracted from annual reports of fixed-wing aerial trend
counts (Wyoming Game and Fish Department 2007). In
this feedground, vaccination with strain 19 has been
implemented since 1985, reaching more than 95% coverage
of all calves (Scurlock and Edwards 2010). The second
dataset included 107 female elk that were tested during
multiple years from different feedgrounds. This dataset
included a total of 243 samples (with 25 antibody losses)
collected from ten different Wyoming feedgrounds between
1995 and 2011. The third dataset included 258 collared
female elk from 21 feedgrounds and other areas of
Wyoming provided by Wyoming Game and Fish Depart-
ment (WGFD) that were tagged from 2007 to 2012 and
tested for brucellosis serological status when the collar was
attached and removed. Collars were attached between
January and March and deployed during one to three years.
Statistical Analyses
The effect of age on seroprevalence was tested from the first
dataset using a generalized linear model (GLM) with a
binomial error and a logit link function using the software
R v.3.2.0 (R Development Core Team 2014). This model
also included the year of sampling as a categorical inde-
pendent variable, which controlled for annual variation in
brucellosis transmission. We also tested separately the effect
of the elk population size per year using the above variables
as controls. Since 22% of individuals were sampled more
than once, results of this model were also confirmed with a
generalized linear model choosing randomly only one
sample per individual, which produced similar results.
Antibody Loss Estimation From the Age–Sero-
prevalence Curve Using the ABC-SMC
Brucellosis Transmission Models
We compared the ability of three different epidemiological
models to recreate the age–seroprevalence curve observed in
our first dataset by developing three different stochastic
discrete-time individual-based models representing the
spread of brucellosis within females of an elk population: (1)
a susceptible-infectious-recovered (SIR) model with no
antibody loss, referred as the ‘No antibody loss’ model, (2) a
SIRSmodelwith antibody loss and loss of immunity, referred
as the ‘Antibody loss and loss of immunity’ model and (3) a
SIRN model with antibody loss and lifelong immunity, re-
ferred as the ‘Antibody loss and lifelong immunity’ model.
Individuals in the N class recover from the disease, are no
longer susceptible to reinfection, but are seronegative (Ta-
ble 1). In these models, the recovered category represents
individuals that are seropositive but are no longer infectious.
We assumed that individuals in the I and R classes tested
positive for antibodies, whereas individuals in the S and N
classes tested negative. For the last twomodels, an additional
version was also implemented including a multi-compart-
mental ‘box-car’ approach (Keeling and Rohani 2008) to
create recovered periods (class R) that were roughly log-
normally distributed (Lloyd 2001; Wearing et al. 2005).
Thesemodels were referred to as ‘Slow antibody loss and loss
of immunity’ and the ‘Slow antibody loss and lifelong
immunity’ models. They illustrate scenarios where antibody
loss occurs several years after recovering from the disease,
because antibodies usually decrease for several years before
reaching an undetectable level in humans (Farrell et al. 1975).
To simplify the analyses, we did not account for year-to-year
variation, but ran the model to a steady state. We modeled
the probability of transmission to a given susceptible in year t
as 1 - (1 - b)I(t). Mortality rates and population size
(N = 800 individuals) were constant in the model, because
we do not expect demographic parameters to affect the shape
of the age–seroprevalence curve and therefore the estimation
of the probability of antibody loss. Additional details on all
models are provided in Sect. 3 of SupplementaryMaterial.R0
was approximated in each model to R0  b Z
1 cþ 1cð Þlð Þð Þ
cþ 1cð Þlð Þ with b = transmission probability, Z = total
population size, c = recovery probability and l = average of
the age-specific mortality probabilities weighted by the age
distribution (details are given in Sect. 4 of Supplementary
Material). The vaccination coverage needed to eradicate the
disease was calculated as 1 1R0 (Dietz 1993).
Parameter Estimation Using ABC-SMC
Traditionally, epidemiological parameters have been esti-
mated from the age–seroprevalence curve using different
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versions of the catalytic model (Hens et al. 2010), allowing
maximum-likelihood estimations. However, the catalytic
model applies generally to age–seroprevalence curves
increasing with age and is often constrained by assump-
tions such as long-lived antibodies (Caley and Hone 2002;
Grenfell and Anderson 1985; Heisey et al. 2006; Hens et al.
2010). This approach is not suited to disentangle more
complex scenarios of antibody loss such as the ones de-
scribed above, where disease prevalence could also decay in
older individuals. The difficulty of writing a closed-form
likelihood function of the age–prevalence data given the
parameters (especially for the model with slow antibody
loss) complicates the use of standard MCMC techniques
for model inference. Instead, we used an approximate
Bayesian computation-sequential Monte Carlo (ABC-
SMC) approach (Toni et al. 2009) to estimate epidemio-
logical parameters from the age–prevalence curve obtained
from the first dataset and to compare models of within-
host brucellosis. The ABC method replaces the calculation
of the likelihood with a comparison between the observed
and simulated data using a ‘distance metric.’ Briefly, the
distance metric used here was the sum of squared differ-
ences between the observed and simulated prevalence at
each age category weighted by its sample size, given by
SS ¼P19i¼1 ei  oið Þ2Ai where Ai is the number of samples
collected at age i and ei and oi are the simulated and ob-
served prevalence at age i, respectively. Further details of
this procedure are provided in Sect. 3 of Supplementary
Material.
Antibody Loss Estimation from Animals Sampled
Multiple Years
Independently from the ABC-SMC, we used the second
dataset including multiple year sampling to estimate the
probability of antibody loss using a time-to-failure ap-
proach in a GLM. Details of this analysis are provided in
Sect. 2 of Supplementary Material.
Disease-Induced Mortality Analysis
Brucellosis is not known to cause acute mortality, but it is
associated with lesions in the joints and arthritis, which
may increase mortality rates of a prey species and is a
potential alternative mechanism for a declining sero-
prevalence in older individuals (Thorne et al. 1978). Sur-
vival was estimated from the third dataset using both a
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GLM and a Cox proportional hazard (CPH) model ap-
proach (details on Sect. 5 of Supplementary Material). The
same significant results were obtained using a CPH mixed
effect model including individual ID as random effect using
the coxme package in R.
RESULTS
The total seroprevalence of brucellosis in elk females with
known ages captured from the Grey’s River feedground was
23.8% (114/478), with an expected percentage of false
positives being less than 8% based on a test specificity of
90% and a sensitivity of 100% (Gall et al. 2001). The age–
seroprevalence curve of brucellosis estimated from the first
dataset in female elk had a concave down shape, with a
decrease in seroprevalence in females aged 10 and older
(Figure 1). A model explaining serological status with a
second-degree polynomial effect of age and sampling
year (GLM with binomial error, age2 estimate ± SD:
-11.21 ± 2.84, z-value 2456 = -3.75, P < 0.001) fit the
data better than a model including only age and sampling
year as independent variables (log-likelihood test,
X2 = 19.52, df = 1, P < 0.001). During the study period,
Grey’s River feedground had an average ± SD elk popu-
lation size of 792 ± 169, ranging from 491 to 1100 indi-
viduals. Seroprevalence was not affected by the elk
population size (GLM including age, year of sampling and
population size). A second-degree polynomial on age was
significant in all combinations of model tested (including
or not year of sampling and population size), and the shape
of the curve remained unchanged when controlling for
sampling year.
The probability of antibody loss estimated from the
second dataset including females sampled multiple times
was 0.07 year -1 [95% CI 0.05–0.11]. Among 25 females
who lost their antibody titers, 18 lost them within the first
subsequent test. Considering that 8% of these 18 events
could be attributed to false positives (see Sect. 2 of Sup-
plementary Material), we reran this last analysis randomly
excluding two samples (which encompassed the 8% false
positives) and found no significant difference in the esti-
mates.
We found no evidence for an influence of serological
status on elk survival using a GLM to analyze the collar data
of 258 female elk (mortality rate for seronegative individ-
uals = 0.03 [95% CI 0.00–0.16], positive status odds ra-
tio = 0.87 [95% CI 0.28–2.52]). Likewise, no influence of
serological status was found using the CPH analysis (pos-
itive status odds ratio = 0.79 [95% CI 0.32–1.93]). There-
fore, we did not include brucellosis-induced mortality in
the simulation models. As an additional test to indepen-
dently assess the potential role of disease-induced mortal-
ity, we estimated the age–seroprevalence curve using the
upper end of the 95% confidence interval of the estimated
disease-induced mortality from the above analyses (i.e.,
odds ratio = 2.52). This was achieved using the Heisey
et al. (2006) formula, which is, to our knowledge, one of
the only estimation methods of the age–seroprevalence
curve with disease-induced mortality. We found that dis-
ease-induced mortality alone cannot generate a decrease in
seroprevalence in older individuals (results shown in
Sect. 5 of Supplementary Material).
Only the SIRN models including lifelong immunity
after antibody loss predicted a significant decline in the
seroprevalence of older individuals as observed in the
empirical data (Figure 2a). The SIR model generated a
monotonic increase in seroprevalence with age, while
models with antibody loss and loss of immunity predicted a
minor decline in the seroprevalence of older individuals.
This result was also reflected on the goodness-of-fit SS
metric used in the ABC-SMC procedure, where the ‘Slow
antibody loss and lifelong immunity’ model fit the empir-
ical data the best (Figure 2b) and had an estimated annual
probability of antibody loss around 0.70, with zero prob-
ability of being smaller than 0.3 (Figure 3). In different
versions of this model, a five box-car model (mean ± SD
Figure 1. Empirical age–seroprevalence curve for female elk. The
gray line represents the prediction based on the GLM model where
seroprevalence is explained by age, age2 and year of collection. Error
bars correspond to the 95% confidence interval. Sample sizes for age
classes 1 to 19 years old were 16, 234, 82, 54, 26, 20, 10, 7, 6, 6, 5, 1, 3,
1, 1, 3, 1, 1, 1, respectively.
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of SS = 4.84 ± 0.76) fit the data marginally better than the
three (mean ± SD of SS = 5.07 ± 0.77) or four
(mean ± SD of SS 5.02 ± 0.75) box-car models. Posterior
distributions for all models are provided in supplementary
Table S1.
R0 for the SIR model was estimated to a mean of 1.88
[95% CI 1.46–2.41]. In models with antibody loss and loss
of immunity, R0 was 1.66 [95% CI 1.35–2.08] (SIRS) and
1.77 [95% CI 1.45–2.22] (SIRS with slow antibody loss). In
models with antibody loss and lifelong immunity, R0 was
2.25 [95% CI 1.67–3.07] (SIRN) and 2.13 [95% CI 1.60–
2.78] (SIRN with slow antibody loss) (Figure 4 and sup-
plementary Table S1). The percentage of the population
(averaged across the best 1000 simulations) that needs to be
vaccinated to eradicate the disease was 47, 56 and 53% for
the SIR, SIRN and SIRN with slow antibody loss, respec-
tively. The N class represented an averaged 25% (range 4–
45%) and 18% (range 4–33%) of the entire female popu-
lation in the SIRN and SIRN with slow antibody loss,
respectively. In the sample used to estimate the age–sero-
prevalence curve with the ABC-SMC, they represented only
4% (range 0–13%) and 2% (range 0–8%) of the 478 female
elk sampled. The waiting time in the recovered class reflects
the duration of antibodies at detectable levels. This waiting
time was estimated for the SIRN and SIRN with slow
antibody loss model from the best 1000 simulations and
Figure 2. Predicted age–seroprevalence curve by different alternative models of within-host brucellosis dynamics. In (A), each curve is
predicted by different models using the loess smooth function averaging the 1000 best simulations selected by the ABC-SMC procedure. Dashed
lines represent models with a waiting time in the R class (i.e., ‘Slow Antibody loss models’). Gray lines represent the two models showing a
significant decline in seroprevalence in older individuals, also shown in gray-colored boxplots on the plot (B) for comparison. In (B), the sum of
squared differences between the empirical and the predicted data (SS metric) is summarized from the best 1000 simulations selected by the
ABC-SMC. Boxplot shows the median, 25% quartiles and extreme values.
Figure 3. Posterior distribution for the SIRN-box model. Posterior (dark gray bars) and prior (light gray bars) distributions for each parameter
(R0, recover probability c and antibody loss probability d) estimated using the ABC-SMC procedure are shown for the ‘Slow antibody loss and
lifelong immunity’ model. A strong prior distribution was chosen for c following Thorne et al. (1978). The prior distribution for the parameter
R0 is not shown given its wide range (0–177, median = 14.35).
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had a median of 4 years (range 1–30) and 8 years (range 5–
24), respectively.
DISCUSSION
Our results suggest that antibody loss and subsequent
lifelong immunity are mechanisms explaining the decline in
brucellosis seroprevalence with age observed in elk. The
declining seroprevalence among elk aged 10 and older was
unlikely to be due to survival differences. We found no
effect of seropositive status on elk survival, and even using
the upper 95th percentile of the survival difference was not
enough to create the observed decline in seroprevalence. To
our knowledge, this is the first study of a wildlife species to
estimate the probability of antibody loss and account for
this phenomenon in the estimation of vaccination cover-
age.
Most wildlife diseases exhibit a monotonic increase in
seroprevalence with age (Cleaveland et al. 2000; Farrington
et al. 2001; Packer et al. 1999). Therefore, the (serological
positive) recovery stage is assumed to be lifelong and
antibody loss is neglected in most systems focusing on
seroprevalence. Our results challenge the assumption of
lifelong antibodies for brucellosis in elk. First, evidence of
antibody loss is supported by our empirical dataset in 25
females. Secondly, the age–seroprevalence curve of brucel-
losis decreases with age, which our model suggests a con-
sequence of antibody loss and subsequent immunity not
involving antibodies. The average probability of antibody
loss estimated from the GLM approach (0.07 year-1) was
smaller than the probability estimated using the ABC-SMC
method for the equivalent model with antibody loss and
lifelong immunity (0.14 year-1), but with an overlapping
of the 95% confidence interval and 95% credible interval of
these estimates.
The ability to detect antibody loss will depend on the
proportion of the population affected by this phenomenon
and the sample size available for that part of the popula-
tion. A small number of antibody loss events that occur one
year after infection may be caused by either false positives
to the test or by individuals that were exposed to the disease
but did not develop a strong antibody response. Further-
more, the large majority of antibody loss events may only
appear after several years (i.e., slow antibody loss models),
thus affecting a very limited proportion of the adult pop-
ulation. For example, we estimated that only 18% of the
entire population belongs to the negative N class. Age
distributions are generally biased toward a small percentage
of old individuals, making it difficult to accurately estimate
whether seroprevalence is decreasing or not in old indi-
viduals. This is the case in our study, although the ABC-
SMC inference proved to be sensitive enough to estimate
parameters despite a small sample size. Particular effort in
sampling old age categories will likely refine those estima-
tions and perhaps allow discriminating between more
complex scenarios (e.g., including disease recrudescence).
The vaccination of juveniles in this population could
also affect antibody prevalence in that age category. How-
ever, if the vaccination of juveniles resulted in
detectable antibodies the following year, one would expect
almost 100% seroprevalence among one- to three-year-old
elk. Instead, these ages tended to have very low sero-
prevalence that was gradually increasing as would be ex-
pected from natural exposures rather than a juvenile only
vaccination program that covers the majority of the juve-
nile population (Scurlock and Edwards 2010). In addition,
a parallel study on elk in the region indicated that 16% of
seropositive pregnant female elk had abortions compared
Figure 4. Comparison of R0 estimations in different models. The
estimated R0 considering only females are infectious in the
population is summarized from the best 1000 simulations selected
by the ABC-SMC procedure for each model. Boxplots generated
using R show the median, 25% quartiles and extreme values. For
comparison with Figure 1, gray-colored boxplots indicate models
with antibody loss and lifelong immunity. Details on the calculation
of R0 are provided in Sect. 5 of Supplementary Material.
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to only 2% of seronegative elk (Cross et al. 2015; Etter and
Drew 2006). Thus, we believe our results apply to natural
exposures of elk to B. abortus and the subsequent loss of
antibodies to those natural exposures, rather than some
artifact of the vaccination program (Maichak et al. 2017).
The percentage of the N class in the population should
also affect the estimation of other epidemiological param-
eters including vaccination coverage. Estimations of R0
increased by less than 20% in models accounting for
antibody loss, because this phenomenon affects only a small
percentage of the population. R0 for brucellosis has been
estimated to be 1.76 in bison (Hobbs et al. 2015), but no
formal calculation has been made for elk. In this study, R0
was estimated to be 2.13 for the model with slow antibody
loss that best fit the data and 1.88 for the model without
antibody loss. If antibody loss happens early in life relative
to the species lifetime, we expect that the underestimation
of a higher percentage of negative individuals wrongly
considered as susceptible might affect the estimation of R0
more considerably. The estimated vaccination coverage
needed to eradicate brucellosis in this elk population, di-
rectly derived from R0 estimates, is an essential tool for
planning vaccination programs such as those established at
Wyoming feedgrounds (Scurlock and Edwards 2010).
Current vaccines available for elk are not fully protective
against infection (Cross et al. 2007; Kreeger et al. 2002;
Olsen et al. 2006), but our results suggest that if an effective
vaccine was available, then the vaccination program should
plan to cover at least half of the female population to
eradicate the disease. This amount of coverage is easily
attained on the supplemental feeding grounds where
managers routinely remotely vaccinate in excess of 90% of
the calves every year, but would be very difficult in other
free-ranging elk populations. Further work would be nee-
ded to estimate vaccination coverage on a more realistic
scenario using a partially protective vaccine (Arenas-
Gamboa et al. 2009).
Our model predictions favor the existence of a lifelong
adaptive immune response to brucellosis after the first
infection, but that this immunity is not reflected in the
current serological assays. Although there is an incomplete
understanding of the immune mechanism involved in
Brucella infection, this prediction is in agreement with the
proposition that T cell-mediated immunity is an important
mechanism to fight brucellosis infection (Yingst and Ho-
over 2003). In fact, cell-mediated immunity has been sug-
gested both as a mechanism explaining protection to the
RB51 vaccine in cattle (Stevens et al. 1994) and as the most
important immunological long-term response for bison
brucellosis (Olsen 2010). Although cell-mediated immunity
can also trigger antibody production during a secondary
infection, T cells do not seem to be associated with anti-
body production in the brucellosis immunological response
(Gill et al. 1992). Given the low number of samples in older
individuals used to estimate the age–seroprevalence curve,
a more conclusive discrimination between titer loss models
with or without lifelong adaptive immunity (SIRN versus
SIRS) will require further work. This could include the
noninvasive measurement of specific cell-mediated
immunity proteins against brucellosis such as cytokines in
individuals experiencing antibody loss. Immunological
scenarios combining both a humoral and cell-mediated
long-term immunity are plausible, but our empirical data
do not have enough statistical power to discriminate be-
tween more complex scenarios that could all generate a
decrease in seroprevalence with age. Likewise, further work
is needed to establish the importance of disease latency and
recrudescence of brucellosis in elk, and whether that could
influence the observed patterns of seropositivity.
Other than antibody loss, disease-induced mortality
can also generate a decrease in prevalence in older indi-
viduals (Benavides et al. 2012). A study on bison showed
that brucellosis alone had little or no effect on survival (Joly
and Messier 2005). Likewise, our analyses show no evidence
for brucellosis-induced mortality in female elk, although
parameter estimations were highly variable. Furthermore,
we did not find a decrease in seroprevalence with age when
accounting for disease-induced mortality using the formula
described by Heisey et al. (2006). In other systems, anti-
body loss and disease-induced mortality may co-occur and
it may be difficult to disentangle these two mechanisms
using only the relationship between age and seroprevalence.
Ancillary data on one of the factors in isolation may be
required. Alternatively to disease-induced mortality, re-
duced contact between old individuals and other members
of the population could prevent them from becoming re-
exposed to brucellosis, also generating lower seroprevalence
in that age category. However, previous studies have found
inconclusive evidence of individual differences in elk–fetus
contact rates at feedgrounds (Creech et al. 2012) or low
individual variation in contact between females compared
to other factors (Cross et al. 2013).
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CONCLUSION
Our study suggests antibody loss and subsequent cell-me-
diated lifelong immunity as the within-host dynamics of
brucellosis in elk. Antibody loss has also been suggested in
older bison individuals (Joly andMessier 2004). Therefore, it
may be a common issue that is seldom recognized in wildlife
disease studies. Our results also suggest that antibody loss
and subsequent loss of immunity only generate a minor
decrease in seroprevalence with age, which could be unde-
tected in small sample sizes and confounded with no anti-
body loss. This calls for a re-evaluation of the assumption of
long-lived antibodies made in most studies estimating epi-
demiological parameters from serological data.
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